The investment portfolio of Octopus AIM VCT plc (the "Company") as at 14 June 2017 is as follows (the valuations being the unaudited valuations, at bid price, as at 31 May 2017):
| Investee Company | Sector | Book cost (£000) | Movement in valuation (£000) | Fair Value (£000) |
| Breedon Group plc | Construction & Building | 859 | 5,437 | 6,296 |
| Quixant plc | Technology Hardware | 697 | 5,252 | 5,949 |
| Staffline Recruitment Group plc | Support Services | 334 | 4,915 | 5,249 |
| GB Group plc | Support Services | 715 | 3,946 | 4,661 |
| Brooks Macdonald Group plc | Finance | 746 | 3,111 | 3,857 |
| IDOX plc | Software | 353 | 3,072 | 3,425 |
| Gear4music Holdings plc | Media | 557 | 2,671 | 3,228 |
| Mattioli Woods plc | Finance | 529 | 2,694 | 3,223 |
| Learning Technologies Group plc | Support Services | 1,319 | 1,512 | 2,831 |
| RWS Holdings plc | Support Services | 367 | 2,047 | 2,414 |
| Animalcare Group plc | Pharmaceuticals & Biotech | 306 | 1,851 | 2,157 |
| Netcall plc | Telecommunication Services | 308 | 1,661 | 1,969 |
| Ergomed plc | Pharmaceuticals & Biotech | 1,440 | 342 | 1,782 |
| Craneware plc | Software | 183 | 1,597 | 1,780 |
| DP Poland plc | Leisure & Hotels | 546 | 1,147 | 1,693 |
| Gooch & Housego plc | Electronic & Electrical | 489 | 1,177 | 1,666 |
| Cello Group plc | Media | 895 | 727 | 1,622 |
| Yu Group plc | Utilities | 705 | 857 | 1,562 |
| Restore plc | Support Services | 467 | 1,054 | 1,521 |
| Adept Telecom plc | Telecommunication Services | 601 | 857 | 1,458 |
| Clinigen Group plc | Pharmaceuticals & Biotech | 935 | 440 | 1,375 |
| Advanced Medical Solutions Group plc | Pharmaceuticals & Biotech | 757 | 576 | 1,333 |
| Next Fifteen Communications Group plc | Media | 687 | 625 | 1,312 |
| Vertu Motors plc | General Retailers | 1,265 | (59) | 1,206 |
| EKF Diagnostics Holdings plc | Health | 931 | 204 | 1,135 |
| Brady plc | Software | 947 | 184 | 1,131 |
| Escher Group Holdings plc | Software | 1,003 | 88 | 1,091 |
| TLA Worldwide plc | Media | 807 | 282 | 1,089 |
| CityFibre plc | Telecommunication Services | 1,025 | 62 | 1,087 |
| Ideagen plc | Software | 419 | 650 | 1,069 |
| Omega Diagnostics Group plc | Health | 465 | 549 | 1,014 |
| Escape Hunt plc | Leisure & Hotels | 988 | 0 | 988 |
| Futura Medical plc | Pharmaceuticals & Biotech | 968 | (34) | 934 |
| Judges Scientific plc | Electronic & Electrical | 314 | 571 | 885 |
| Abcam plc | Pharmaceuticals & Biotech | 537 | 344 | 881 |
| Tasty plc | Leisure & Hotels | 622 | 242 | 864 |
| Cambridge Cognition Holdings plc | Health | 601 | 257 | 858 |
| Nasstar plc | Software | 481 | 336 | 817 |
| Velocity Composites plc | Industrial | 799 | 0 | 799 |
| Faron Pharmaceuticals Oy | Pharmaceuticals & Biotech | 344 | 403 | 747 |
| LoopUp Group plc | Software | 480 | 254 | 734 |
| Gamma Communications plc | Telecommunication Services | 488 | 241 | 729 |
| Vectura Group plc | Pharmaceuticals & Biotech | 498 | 208 | 706 |
| Haydale Graphene Industries plc | Chemicals | 598 | 75 | 673 |
| Mears Group plc | Support Services | 139 | 487 | 626 |
| SQS Software Quality Systems AG | Software | 291 | 283 | 574 |
| Scientific Digital Imaging plc | Electronic & Electrical | 179 | 368 | 547 |
| Sinclair IS Pharma plc | Pharmaceuticals & Biotech | 765 | (256) | 509 |
| Maxcyte Inc | Pharmaceuticals & Biotech | 511 | (28) | 483 |
| Plastics Capital plc | Engineering & Machinery | 400 | 60 | 460 |
| Iomart Group plc | Software | 268 | 184 | 452 |
| MyCelx Technologies Corporation | Oil Equipment | 1,470 | (1,019) | 451 |
| Osirium Technologies plc | Electronic & Electrical | 750 | (312) | 438 |
| UP Global Sourcing Holdings plc | Household Goods & Textiles | 273 | 158 | 431 |
| WANdisco plc | Software | 145 | 229 | 374 |
| FreeAgent Holdings plc | Media | 277 | 69 | 346 |
| TP Group plc | Engineering & Machinery | 648 | (315) | 333 |
| Access Intelligence plc | Software | 495 | (75) | 420 |
| Microsaic Systems plc | Engineering & Machinery | 1,084 | (802) | 282 |
| Sphere Medical Holding plc | Health | 600 | (328) | 272 |
| Enteq Upstream plc | Oil Services | 1,032 | (774) | 258 |
| Midatech Pharma plc | Pharmaceuticals & Biotech | 600 | (364) | 236 |
| Hasgrove plc* | Media | 88 | 132 | 220 |
| Nektan Limited | Software | 1,345 | (630) | 715 |
| Oxford Pharmascience Group plc | Pharmaceuticals & Biotech | 1,350 | (1,148) | 202 |
| Tyratech Inc | Chemicals | 600 | (420) | 180 |
| Medica Group plc | Health | 95 | 61 | 156 |
| ReNeuron Group plc | Pharmaceuticals & Biotech | 324 | (201) | 123 |
| Genedrive Plc | Pharmaceuticals & Biotech | 210 | (105) | 105 |
| Dods Group plc | Media | 203 | (102) | 101 |
| Rated People Ltd* | Software | 354 | (267) | 87 |
| Fusionex International plc | Software | 282 | (199) | 83 |
| Proxama plc | Software | 763 | (705) | 58 |
| 1Spatial plc | Software | 300 | (267) | 33 |
| Work Group plc | Support Services | 755 | (727) | 28 |
| Bond International Software plc | Software | 8 | 0 | 8 |
Current Liquidity Investments
| Investee Company | Sector | Book cost (£000) | Movement in valuation (£000) | Fair Value (£000) |
| Octopus Portfolio Manager - Conservative Capital Growth | n/a | 5,350 | 398 | 5,748 |
| Octopus Portfolio Manager - Defensive Capital Growth | n/a | 5,350 | 279 | 5,629 |
| Money Market Funds | n/a | 5,290 | 3 | 5,293 |
| Octopus UK Micro Cap Growth Fund | n/a | 1,650 | 444 | 2,094 |
Since 31 May 2017 there has been one follow on investment with a cost of £470,000.
Since 31 May 2017 there has been one disposal, the proceeds of which totalled £156,000 (cost £122,000).
| Unless otherwise stated, all the investments set out above : |
| 1. are quoted on AIM or on the London Stock Exchange Full List: |
| 2. represent equity investments except in the case of Nektan and Access Intelligence which include investment via loan stock: and |
| 3. are in portfolio companies incorporated in the UK with the exception of: |
| Escher - Ireland |
| Mycelx - USA |
| SQS - Germany |
| Nektan - Gibraltar |
| Faron Pharmaceuticals Oy - Finland |
| MayCyte Inc - USA |
| *Denotes private company |
For further information, please contact:
Nicola Board
Octopus Investments Limited
Tel: 0800 316 2295